Gastric lesions in transforming growth factor β-1 heterozygous mice

Laboratory Investigation

Volumn 74, Issue 2, 1996, Pages 513-518

  Boivin, Gregory P ^a   Molina, Julian R ^a   Ormsby, Ilona ^a   Stemmermann, Grant ^a   Doetschman, Thomas ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ALLELE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; GASTRITIS; GENOTYPE; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH LESION; VASCULITIS;

ALLELES; ANIMALS; GASTRIC MUCOSA; GASTRITIS; GENOTYPE; HETEROZYGOTE; HYBRIDIZATION, GENETIC; HYPERPLASIA; MICE; MICE, INBRED STRAINS; STOMACH; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030069171     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Barnard JA, Beauchamp RD, Coffey RJ, and Moses HL (1989). Regulation of intestinal epithelial cell growth by transforming growth factor type β. Proc Natl Acad Sci USA 86:1578-1582.
2. Barnard JA, Coffey RJ, Pelton RW, and Moses HL (1990a). Distribution of transforming growth factor β (TGFβ) mRNA and protein in the small intestine (abstract). Gastroenterology 98:A483.
3. Barnard JA, Lyons RM, and Moses HL (1990b). The cell biology of transforming growth factor beta. Biochim Biophys Acta 1032:79-87.
4. Basson MD, Modlin IM, Flynn SD, Jena BP, and Madri JA (1992). Independent modulation of enterocyte migration and proliferation by growth factors, matrix proteins, and pharmacologie agents in an in vitro model of mucosal healing. Surgery 112:299-307.
5. Boivin GP, O'Toole BA, Ormsby IE, Diebold RJ, Eis MJ, Doetschman TC, and Kier AB (1995). Onset and progression of pathological lesions in transforming growth factor-beta-1-deficient mice. Am J Pathol 146:276-288.
6. Ciacci C, Lind SE, and Podolsky DK (1993). Transforming growth factor beta regulation of migration in wounded rat intestinal epithelial monolayers. Gastroenterology 105:93-101.
7. Diebold RJ, Eis MJ, Yin M, Boivin GP, Darrow B, Saffitz J, and Doetschman T (1995). Early onset multifocal inflammation in the TGFβ1-null mouse is lymphocyte mediated. Proc Natl Acad Sci USA.
8. Franzin G, Musola R, Zamboni G, and Manfrini C (1985). Gastritis cystica polyposa: A possible precancerous lesion. Tumori 71:13-18.
9. Hannon GJ, and Beach D (1994). p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371: 257-261.
10. Ito M, Yasui W, Kyo E, Yokozaki H, Nakayama H, Ito H, and Tahara E (1992). Growth inhibition of transforming growth factor beta on human gastric carcinoma cells: Receptor and postreceptor signaling. Cancer Res 52:295-300.
11. Ko TC, Beauchamp RD, Townsend CM Jr, Thompson EA, and Thompson JC (1992). Transforming growth factor-beta inhibits rat intestinal cell growth by regulating cell cycle specific gene expression. Am J Surg 167:14-19.
12. Koga S, Watanabe H, and Enjoji M (1979). Stomal polypoid hypertrophic gastritis: A polypoid gastric lesion at gastroenterostomy site. Cancer 43:647-657.
13. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, and Karlsson S (1993). Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90:770-774.
14. Kulkarni AB, Ward JM, Yaswen L, Mackall CL, Bauer SR, Huh CG, Gress RE, and Karlsson S (1995). Transforming growth factor-beta 1 null mice: An animal model for inflammatory disorders. Am J Pathol 146:264-275.
15. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, and Massague J (1990). Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175-185.
16. Massague J (1990). The transforming growth factor-beta family. Annu Rev Cell Biol 6:597-641.
17. Ozenc AM, Ruacan S, and Aran O (1988). Gastritis cystica polyposa. Arch Surg 123:372-373.
18. Pietenpol JA, Munger K, Howley PM, Stein RW, and Moses HL (1991). Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor beta 1 and by the retinoblastoma gene product. Proc Natl Acad Sci USA 88:10227-10231.
19. Poel WE, Ciocco A, and Doolittle DP (1968). Unusual neoplasms and hyperplastic lesions in "random-bred" mice derived from four-way crossed inbred lines. Cancer Res 28:845-849.
20. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, and Koff A (1994). p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 8:9-22.
21. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, and Doetschman T (1992). Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359:693-699.
22. Sporn MB, and Roberts AB (1985). Autocrine growth factors and cancer. Nature 313:745-747.
23. Sporn MB, Roberts AB, Wakefield LM, and de Crombrugghe B (1987). Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 105:1039-1045.
24. St. John DJ, Yeomans ND, Bourne CA, and de Boer WG (1977). Aspirin-induced glandular dysplasia of the stomach: Histologie and histochemical studies in rats. Arch Pathol Lab Med 101:44-48.
25. Stewart H (1941). Hyperplastic and neoplastic lesions of the stomach in mice. J Natl Cancer Inst 1:489-502.
26. Stewart HL, and Andervont HB (1938). Pathologic observations on the adenomatous lesion of the stomach in mice of strain I. Arch Pathol 26:1009-1022.
27. Toyoshima H, and Hunter T (1994). p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74.
28. Tucker RF, Shipley GD, Moses HL, Holley RW (1984). Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor. Science 226:705-707.
29. Wyllie AH (1980). Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556.
30. Yanagihara K, and Tsumuraya M (1992). Transforming growth factor beta 1 induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res 52:4042-4045.